Discover scientific publications on pharmacovigilance
Original research and thinking in the science of pharmacovigilance
This is a non-exhaustive list of scientific papers with key authors from the UMC. Most of the references link to full articles.
211 documents found.
-
Scientific publicationsThe Role of the WHO Programme on International Drug Monitoring in Coordinating Worldwide Drug Safety Efforts
The rationale for setting up the WHO International Programme for Adverse Reaction Monitoring, 30 years ago was to make it possible to identify rare adverse drug reactions (ADRs) that could not be found through clinical trial programmes.Drug Saf. 1998;19(1):1-10.
Author: Sten Olsson
Date: 1998-07-01 -
Scientific publicationsCausal or Casual? The Role of Causality Assessment in Pharmacovigilance
As with any other study method, ‘spontaneous reporting’ in pharmacovigilance is a process of data acquisition, assessment, presentation and interpretation.Drug Saf. 1997;17(6):374-89.
Author: Ronald H. B. Meyboom, Yechiel A. Hekster, Antoine C. G. Egberts, Frank W. J. Gribnau, I. Ralph Edwards
Date: 1997-12-01 -
Scientific publicationsThe Challenge of Effectively Communicating Risk-Benefit Information
Although the techniques involved in drug safety monitoring (pharmacovigilance) have dramatically improved in recent years, communication of these issues to health professionals and the public lags far behind.Drug Saf. 1997;17(4):216-27.
Author: I. Ralph Edwards, Bruce Hugman
Date: 1997-10-01 -
Scientific publicationsPrinciples of Signal Detection in Pharmacovigilance
Adverse drug effects are manifold and heterogenous.Drug Saf. 1997;16(6):355-65.
Author: Ronald H. B. Meyboom, Antoine C. G. Egberts, I. Ralph Edwards, Yechiel A. Hekster, Fred H. P. de Koning, Frank W. J. Gribnau
Date: 1997-06-01 -
Scientific publications
Who cares about pharmacovigilance?
European Journal of Clinical Pharmacology. October 1997, Volume 53, Issue 2, pp 83–88.
Author: I. R. Edwards
Date: 1997-05-27 -
Scientific publicationsConcepts in Risk-Benefit Assessment - A Simple Merit Analysis of a Medicine?
The term ‘benefit-risk ratio’ is often used as a general term linked to the use of a medicine.Drug Saf. 1996;15(1):1-7.
Author: I. Ralph Edwards, Bengt-Erik Wiholm, Carlos Martinez
Date: 1996-07-01 -
Scientific publicationsHarmonisation in Pharmacovigilance
Throughout the world there is considerable activity in the area of drug safety, pharmacovigilance and pharmacoepidemiology.Drug Saf. 1994;10(2):93-102.
Author: I. Ralph Edwards, Cecilia Biriell
Date: 1992-02-01 -
Scientific publications
Skin reactions and fever with indapamide.
BMJ. 1987;295:1313.
Author: Stricker BHC, Biriell C.
Date: 1987-11-21 -
Scientific publications
Skin reactions to terfenadine.
Br Med J (Clin Res Ed) 1986;293:536.
Author: Stricker BH, va Dijke CPH, Isaacs AJ, Lindquist M.
Date: 1986-08-30 -
Scientific publications
Acute hypersensitivity reactions to paracetamol.
BMJ. 1985;291:938-9.
Author: Stricker BHC, Meyboom RHB, Lindquist M.
Date: 1985-10-05 -
Scientific publications
Photosensitivity during treatment with azapropazone.
Br Med J (Clin Res Ed) 1985;291:939.
Author: Olsson S, Biriell C, Boman G.
Date: 1985-10-05